Mutations in the Txnip PPXY motifs protect against myocardial infarction despite enhanced protein stability
Yoshinobu Nakayama1, Atsuhiro Kitaura1, Syed Amir Abdali1
1Department of Molecular, Cellular & Biomedical Sciences, City University of New York School of Medicine, New York, New York, United States.
Abstract:
Thioredoxin-interacting protein (Txnip), a member of α-arrestin superfamily, is best known for inhibiting thioredoxins and glucose transporters, increasing oxidative and metabolic stress. Through these functions, Txnip has emerged as a key contributor to the pathogenesis of heart diseases. Txnip contains C-terminal PPXY motifs that are conserved among α-arrestins across diverse species. Nevertheless, the physiological significance of these motifs remains unknown. We demonstrate that mutation of Txnip PPXY motifs to AAXA uncouples Txnip's canonical functions from its cytotoxic effects. Although the mutant reduced glutathione levels and glucose uptake to the same extent as wild-type Txnip, it attenuated cell death. To assess translational relevance, we engineered inducible, cardiomyocyte-restricted Txnip PPXY-to-AAXA knock-in mice. These mice displayed normal cardiac structure and function at baseline but were strongly protected after myocardial infarction, exhibiting improved left ventricular performance and overall survival. Mechanistically, structural modeling identified the E3 ubiquitin ligase ITCH as the principal PPXY-binding partner. The PPXY mutation abolished Txnip ubiquitination and stabilized Txnip protein, revealing a paradoxical dissociation between Txnip levels and cardiotoxicity. Transcriptomic profiling uncovered enrichment of PPAR-α/PGC-1α-associated pathways, although metabolic assays and untargeted lipidomics did not support these findings. Instead, immediate early genes of the Fos/Jun AP-1 network were consistently downregulated after ischemic injury, and AP-1 DNA-binding activity was diminished in PPXY mutant hearts. These results identify the Txnip PPXY motifs as key regulators of Txnip protein turnover and injury-responsive transcriptional programs. Disruption of these motifs stabilizes Txnip yet confers cardioprotection, providing evidence that elevated Txnip levels do not invariably drive cardiotoxicity.NEW & NOTEWORTHY This study reveals that Txnip's conserved PPXY motifs regulate its cytotoxicity independently of its canonical redox and metabolic functions. Mutating motifs (PPXY-to-AAXA) uncouples Txnip function from cell death, stabilizes the protein by preventing Itch-mediated ubiquitination, and confers striking cardioprotection in knock-in mice after myocardial infarction. Despite elevated Txnip levels, mutant hearts show reduced AP-1 signaling and improved survival, demonstrating that PPXY-dependent pathways, not Txnip abundance, drive cardiotoxicity.
Insights
Mutating the PPXY motifs in thioredoxin-interacting protein (Txnip) stabilizes the protein but protects the heart from injury. This suggests Txnip levels do not always correlate with cardiotoxicity, offering new therapeutic avenues for heart disease.
Area of Science:
- Cardiovascular Biology
- Molecular Mechanisms of Disease
- Protein Regulation
Background:
- Thioredoxin-interacting protein (Txnip) exacerbates heart disease by increasing oxidative and metabolic stress.
- Txnip possesses C-terminal PPXY motifs crucial for α-arrestin function, but their role in Txnip's cardiotoxicity is unclear.
Purpose of the Study:
- To investigate the physiological role of Txnip's PPXY motifs in regulating its function and cardiotoxicity.
- To determine if disrupting these motifs can offer cardioprotection.
Main Methods:
- Utilized site-directed mutagenesis to alter Txnip PPXY motifs to AAXA in cell culture and engineered inducible, cardiomyocyte-restricted knock-in mice.
- Assessed cellular stress, cell death, cardiac function post-myocardial infarction, protein ubiquitination, and transcriptional changes.
- Employed structural modeling to identify binding partners and transcriptomic profiling.
Main Results:
- Mutant Txnip (PPXY-to-AAXA) retained canonical functions but attenuated cell death.
- Inducible knock-in mice with mutated Txnip were protected against myocardial infarction, showing improved cardiac function and survival.
- The PPXY mutation abolished Txnip ubiquitination by the E3 ligase ITCH, stabilizing Txnip protein and downregulating AP-1 network genes post-injury.
Conclusions:
- Txnip PPXY motifs are critical for regulating Txnip protein turnover and injury-induced transcriptional responses.
- Disrupting these motifs paradoxically stabilizes Txnip protein while conferring significant cardioprotection.
- Elevated Txnip levels do not invariably drive cardiotoxicity, challenging existing paradigms in heart disease pathogenesis.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenomics: Identification of New Drug Targets
Abnormal Proliferation
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Myocarditis I: Introduction


